The described technology enables the fast and competitive production of specific ALA via biotechnological process technology.
On behalf of the University of Bielefeld, PROvendis offers access to rights for commercial use as well as the opportunity for further co-development.
In case of interest we are pleased to inform you about the current patent status.
Zhang et al. Optimization of heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli. Sci Rep. 2015; Feb 26;5:8584. Doi: 10.1038/srep08584